Treatment, survival, and thromboembolic outcomes of thrombotic storm in children

Journal of Pediatrics

Volumn 161, Issue 4, 2012, Pages

  Manco Johnson, Marilyn J ^a,b   Wang, Michael ^a,b   Goldenberg, Neil A ^a,b   Soep, Jennifer ^a   Gibson, Elizabeth ^a,b   Knoll, Christine M ^c   Mourani, Peter M ^a  

^a Children's Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; ENOXAPARIN; FONDAPARINUX; IMMUNOMODULATING AGENT; PHOSPHOLIPID ANTIBODY; THROMBIN INHIBITOR; WARFARIN;

ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ARTICLE; CHILD; CHILDHOOD MORTALITY; CLINICAL ARTICLE; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOMODULATION; MALE; POSTTHROMBOSIS SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENT DISEASE; SCHOOL CHILD; SEROTONIN RELEASE; THROMBOSIS; THROMBOTIC STORM; VENOUS THROMBOEMBOLISM;

EID: 84866728865     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.03.042     Document Type: Article

References (23)

1. L. Raffini, Y.S. Huang, C. Witmer, and C. Feudtner Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007 Pediatrics 124 2009 1001 1008
2. R. Cervera, J. Font, J.A. Gómez-Puerta, G. Espinosa, M. Cucho, S. Bucciarelli for the Catastrophic Antiphospholipid Syndrome Registry Project Group Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome Ann Rheumatol Dis 64 2005 1205 1209 (Pubitemid 41113358)
3. R.A. Asherton The catastrophic antiphospholipid syndrome, 1998: a review of the clinical features, possible pathogenesis and treatment Lupus 7 Suppl 2 1998 S55 S62
4. G. Arepally, and T.L. Ortel Heparin-induced thrombocytopenia Annu Rev Med 61 2010 77 90
5. A. Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 2007 1723 1729 (Pubitemid 47443881)
6. H. Ideguchi, S. Ohno, A. Ueda, and Y. Ishigatsubo Catastrophic antiphospholipid syndrome associated with malignancies Lupus 16 2007 59 64
7. S. Miyakis, M.D. Lockshin, T. Atsumi, D.W. Branch, R.L. Brey, and R. Cervera International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 4 2006 295 306
8. R.A. Asherson The primary, secondary, catastrophic and seronegative variants of the antiphospholipid syndrome: a personal history long in the making Semin Thromb Hemost 34 2008 227 235
9. C.S. Kitchens Thrombotic storm: when thrombosis begets thrombosis Am J Med 104 1998 381 385 (Pubitemid 28211030)
10. P. Monagle, E. Chalmers, A. Chan, G. DeVeber, F. Kirkham, P. Massicotte American College of Chest Physicians Antithrombotic therapy in neonates and children: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition) Chest 133 6 Suppl 2008 887S 968S (Pubitemid 351892979)
11. M.J. Manco-Johnson, E.F. Grabowski, M. Hellgren, A.S. Kemahli, M.P. Massicotte, and W. Muntean Laboratory testing for thrombophilia in pediatric patients Thromb Haemost 88 2002 155 156
12. A.A. Smith, L.J. Jacobson, B.I. Miller, W.E. Hathaway, and M.J. Manco-Johnson A new euglobulin clot lysis assay for global fibrinolysis Thromb Res 112 2003 329 337
13. N.A. Goldenberg, J.D. Durham, R. Knapp-Clevenger, and M.J. Manco-Johnson A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of post-thrombotic syndrome in children Blood 110 2007 45 53 (Pubitemid 47026817)
14. N.A. Goldenberg, E. Pounder, R. Knapp-Clevenger, and M.J. Manco-Johnson Validation of upper extremity post-thrombotic syndrome outcome measurement in children J Pediatr 157 2010 852 855
15. C. Miret, R. Cervera, J.C. Reverter, M. García-Carrasco, M. Ramos, and M. Mollà Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient " seronegative" antiphospholipid syndrome? Clin Exp Rheumatol 15 1997 541 544 (Pubitemid 27408011)
16. P.G. Vlachoyiannopoulos, and J.G. Routsias A novel mechanism of thrombosis in antiphospholipid antibody syndrome J Autoimmun 35 2010 248 255
17. M.A. Kowalska, L. Rauova, and M. Ponz Role of the platelet cytokine platelet factor 4 (PF4) in hemostasis and thrombosis Thromb Res 125 2010 292 296
18. S. Bucchiarelli, D. Erkan, G. Espinosa, and R. Cervera Catastrophic antiphospholipid syndrome: treatment, prognosis and the risk of relapse Clin Rev Allergy Immunol 36 2009 80 84
19. M. Bortolati, P. Marson, F. Fabris, V. Pengo, M. Facchinetti, and G. DeSilvestro Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: report of four cases and review of the literature Autoimmun Rev 8 2009 297 301
20. G. Espinosa, S. Bucciarelli, R.A. Asherson, and R. Cervera Morbidity and mortality in the catastrophic antiphospholipid syndrome: pathophysiology, causes of death and prognostic factors Semin Thromb Hemost 34 2008 290 294
21. N. Goldenberg, R. Knapp-Clevenger, and M.J. Manco-Johnson Elevated plasma factor VIII and D-dimer levels predict poor thrombotic outcomes in children New Engl J Med 351 2004 1081 1088 (Pubitemid 39167512)
22. M.J. Manco-Johnson, and R. Knapp-Clevenger Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency J Pediatr Hematol Oncol 26 2004 25 27 (Pubitemid 38095629)
23. G. Espinosa, and R. Cervera Antiphospholipid syndrome: frequency, main causes and risk factors of mortality Nat Rev Rheumatol 6 2010 296 300